We’re aware that the recent national announcement about Mounjaro (tirzepatide) is generating significant public interest.
West Yorkshire ICB team are developing a set of public FAQs and other resources which will be available in the next couple of weeks.
In the meantime, we wanted to provide you with a short set of key messages regarding Monujaro
- Please do not contact your GP practice – eligible patients will be contacted directly by their practice or the NHS in due course
- Mounjaro is being gradually rolled out in GP practices as part of wider support for people living with obesity
- It is only available to a very limited number of patients in the first year, based on strict NHS criteria
- Eligibility includes a BMI of 40 or more and at least four serious weight-related health conditions
- Patients must also take part in a structured support programme (wraparound care) including healthy eating and physical activity
Page last updated on:
